These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 33645846

  • 21. N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease.
    Moonarmart W, Boswood A, Luis Fuentes V, Brodbelt D, Souttar K, Elliott J.
    J Small Anim Pract; 2010 Feb; 51(2):84-96. PubMed ID: 20070494
    [Abstract] [Full Text] [Related]

  • 22. Auscultatory, echocardiographic, biochemical, nutritional, and environmental characteristics of mitral valve disease in Norfolk terriers.
    Trafny DJ, Freeman LM, Bulmer BJ, MacGregor JM, Rush JE, Meurs KM, Oyama MA.
    J Vet Cardiol; 2012 Mar; 14(1):261-7. PubMed ID: 22364691
    [Abstract] [Full Text] [Related]

  • 23. The effect of treatment with pimobendan in dogs with preclinical mitral valve disease - a placebo-controlled double-blinded crossover study.
    Klein S, Nolte I, Rumstedt K, Sehn M, Raue JF, Weiner F, Treese JS, Beyerbach M, Bach JP.
    BMC Vet Res; 2021 Sep 25; 17(1):310. PubMed ID: 34563187
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency.
    Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, Arisawa K, Kurita T, Nunokawa K, Hirakawa A, Tanaka S, Hirose H.
    J Vet Med Sci; 2009 Jul 25; 71(7):925-9. PubMed ID: 19652480
    [Abstract] [Full Text] [Related]

  • 25. Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease.
    Kaplan JL, Visser LC, Gunther-Harrington CT, Ontiveros ES, Wittenburg LA, Palm CA, Stern JA.
    J Vet Intern Med; 2022 Nov 25; 36(6):1892-1899. PubMed ID: 36098206
    [Abstract] [Full Text] [Related]

  • 26. Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.
    Pelander L, Häggström J, Ley CJ, Ljungvall I.
    J Vet Intern Med; 2017 May 25; 31(3):805-813. PubMed ID: 28370332
    [Abstract] [Full Text] [Related]

  • 27. The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease.
    Boswood A, Dukes-McEwan J, Loureiro J, James RA, Martin M, Stafford-Johnson M, Smith P, Little C, Attree S.
    J Small Anim Pract; 2008 Jan 25; 49(1):26-32. PubMed ID: 18005104
    [Abstract] [Full Text] [Related]

  • 28. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP.
    Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    Pol J Vet Sci; 2018 Dec 25; 21(4):673-680. PubMed ID: 30605282
    [Abstract] [Full Text] [Related]

  • 29. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Dec 25; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 30. Plasma N-terminal pro-brain natriuretic peptide concentrations before and after pericardiocentesis in dogs with cardiac tamponade secondary to spontaneous pericardial effusion.
    Baumwart RD, Hanzlicek AS, Lyon SD, Lee PM.
    J Vet Cardiol; 2017 Oct 25; 19(5):416-420. PubMed ID: 28988688
    [Abstract] [Full Text] [Related]

  • 31. N-Terminal Pro-B-Type Natriuretic Peptide and Phonocardiography in Differentiating Innocent Cardiac Murmurs from Congenital Cardiac Anomalies in Asymptomatic Puppies.
    Marinus SM, van Engelen H, Szatmári V.
    J Vet Intern Med; 2017 May 25; 31(3):661-667. PubMed ID: 28316101
    [Abstract] [Full Text] [Related]

  • 32. [NT-proBNP as a diagnostic marker in dogs with dyspnea and in asymptomatic dogs with heart murmur].
    Haßdenteufel E, Kresken JG, Henrich E, Hildebrandt N, Schneider C, Stosic A, Schneider M.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 May 25; 40(3):171-9. PubMed ID: 22688794
    [Abstract] [Full Text] [Related]

  • 33. Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure.
    Kanno N, Hori Y, Hidaka Y, Chikazawa S, Kanai K, Hoshi F, Itoh N.
    J Vet Med Sci; 2016 May 03; 78(4):535-42. PubMed ID: 26607133
    [Abstract] [Full Text] [Related]

  • 34. Clinical use of submaximal treadmill exercise testing and assessments of cardiac biomarkers NT-proBNP and cTnI in dogs with presymptomatic mitral regurgitation.
    Wall L, Mohr A, Ripoli FL, Schulze N, Penter CD, Hungerbuehler S, Bach JP, Lucas K, Nolte I.
    PLoS One; 2018 May 03; 13(6):e0199023. PubMed ID: 29902265
    [Abstract] [Full Text] [Related]

  • 35. Degenerative mitral valve disease: Survival of dogs attending primary-care practice in England.
    Mattin MJ, Boswood A, Church DB, McGreevy PD, O'Neill DG, Thomson PC, Brodbelt DC.
    Prev Vet Med; 2015 Dec 01; 122(4):436-42. PubMed ID: 26058819
    [Abstract] [Full Text] [Related]

  • 36. Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs.
    Nakamura K, Kawamoto S, Osuga T, Morita T, Sasaki N, Morishita K, Ohta H, Takiguchi M.
    J Vet Intern Med; 2017 Mar 01; 31(2):316-325. PubMed ID: 28145607
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy.
    Ferasin L, Kilkenny E, Ferasin H.
    J Vet Cardiol; 2020 Aug 01; 30():23-31. PubMed ID: 32645686
    [Abstract] [Full Text] [Related]

  • 38. Assessment of serum N-terminal pro-B-type natriuretic peptide concentration for differentiation of congestive heart failure from primary respiratory tract disease as the cause of respiratory signs in dogs.
    Oyama MA, Rush JE, Rozanski EA, Fox PR, Reynolds CA, Gordon SG, Bulmer BJ, Lefbom BK, Brown BA, Lehmkuhl LB, Prosek R, Lesser MB, Kraus MS, Bossbaly MJ, Rapoport GS, Boileau JS.
    J Am Vet Med Assoc; 2009 Dec 01; 235(11):1319-25. PubMed ID: 19951101
    [Abstract] [Full Text] [Related]

  • 39. Use of radiographic measurements to diagnose stage B2 preclinical myxomatous mitral valve disease in dogs.
    Stepien RL, Rak MB, Blume LM.
    J Am Vet Med Assoc; 2020 May 15; 256(10):1129-1136. PubMed ID: 32364449
    [Abstract] [Full Text] [Related]

  • 40. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
    Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M.
    J Am Vet Med Assoc; 2008 May 15; 232(10):1496-503. PubMed ID: 18479239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.